1
2
3
The Today, Tomorrow theme throughout the report provides a way to describe to the investor that everything that Acambis does now has a positive impact for their future.
Much of what Acambis does is quite complex (a pharmaceuticals company producing vaccines for deadly diseases like smallpox and malaria), therefore an illustrative style was chosen to help bring the business of science to life in a more tangible way.
Another feature of this report is the landscape format allowing for a side column in the review and accounts that explains certain financial terminologies and explains the US 20-F reporting standards to outside investors.